Elizabeth Verna, MD
Transplant Hepatology · New York, NYNPI 1801822622
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (35.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Merck at 34.1% of the total. Reporting peaked in 2019 at $2,965 and has fallen 96.0% since, to $119 in 2025.
Across 28 payments — averaging $388.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$4K
- Eisai Inc.$2K
- W. L. Gore & Associates, Inc.$2K
- Sanofi-aventis U.S. LLC$1K
- CSL Behring$380
- Gilead$139
- plus $491 from 6 others
Across 113 payments — averaging $2738.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$97K
- Gilead$77K
- AbbVie$62K
- Intercept Pharmaceuticals, Inc.$41K
- GSK$23K
- Merck$9K
What the payments were for
- Consulting fees$2,40022%
- Speaking & faculty fees$3,82035%
- Grants$7507%
- Travel & lodging$3,03928%
- Food & beverage$8788%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 7 | $3,708 |
| Eisai Inc. | 1 | $2,400 |
| W. L. Gore & Associates, Inc. | 2 | $2,373 |
| Sanofi-aventis U.S. LLC | 3 | $1,396 |
| CSL Behring | 7 | $380 |
| Gilead | 1 | $139 |
| Dova Pharmaceuticals | 1 | $135 |
| Coherus Oncology, Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $98 |
| Regeneron | 1 | $77 |
| Intra-sana Laboratories | 2 | $35 |
| Boston Scientific | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIATORR TIPS Endoprosthesis$2,373
- Epclusa$139
- DOPTELET$135
- Udenyca$125
How this compares
$10,887 in reported general payments places this provider in the 80th percentile of 36 transplant hepatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant hepatology in New York
- Nikolaos PyrsopoulosNew York$251K
- James ParkNew York$81K
- Amon AsgharpourNew York$58K
- Giuseppe CullaroNew York$50K
- Julia WattacherilNew York$37K
- Gene ImNew York$15K
- Rajani SharmaNew York$11K
- Annmarie LiapakisNew York$10K
- Alyson FoxNew York$10K
- Linda LawNew York$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.